ARCHIVES

DCT Board Okays Extension Of Phase 1 Master Agreements, Increase To $4 Million

This article is from The Cancer Letter archive.

Vol. 13 No. 09 | February 27, 1987

Download PDF Visit The Full Archive

Related Articles

Unclear Whether Clinical Trials Benefit Patients, Review Finds

February 27, 2004

House Plan Promises $3.5 Billion For NIH; Cooperative Groups May Get AHRQ Funds

January 23, 2009

DCPC Board Will Consider Revised Concepts For CPRUs

September 18, 1987

Upton Wraps Up Reorganization – DCCR Revamped, No Prevention Division

October 12, 1979

Guest Editorial: Gerard Silvestri calls for uniform guideline for CT screening for lung cancer

July 1, 2011

Minority Trial Participation A Matter of Access, Study Says

December 30, 2005